hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 21:23:39 - browse：1486

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Cholera vaccine supply gets boost as demand surges globally

WSS

Why rehabilitation engineers need to center patients in their research

Illumina names Agilent executive as new CEO

Covid hospitalizations on the rise, Humana says

UnitedHealth financials solid despite Change Healthcare cyberattack

Cancer researcher Catriona Jamieson is sending tumors into space

ALS advocates say criticism of new drugs misses bigger picture

entertainment

hotspot

hotspot

Bright Health sells Medicare Advantage business to Molina

Melinda French Gates resigns from Gates Foundation

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Close Medicare's dangerous gaps in addiction treatment coverage

Activists slam private health insurers over coverage restrictions

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Continuity nursing helped my family in our darkest PICU moments

Exact Sciences stock tumbles despite strong cancer detection sales

Heart attack and stroke risk calculators need revising

Crinetics acromegaly drug succeeds in late

Wikipedia

The 10 drugs up first for Medicare price negotiation

MultiPlan and major insurers sued for alleged medical price

Stem cell treatment guidelines are released by FDA

Cell therapy fails to slow type 1 diabetes, but safety is established

H5N1 bird flu found in pasteurized milk: what we know

Why Novartis is changing the name of its research labs

explore

entertainment

focus

knowledge